Saurabh Nagar

1.1k total citations
62 papers, 775 citations indexed

About

Saurabh Nagar is a scholar working on Pulmonary and Respiratory Medicine, Oncology and Pathology and Forensic Medicine. According to data from OpenAlex, Saurabh Nagar has authored 62 papers receiving a total of 775 indexed citations (citations by other indexed papers that have themselves been cited), including 27 papers in Pulmonary and Respiratory Medicine, 22 papers in Oncology and 11 papers in Pathology and Forensic Medicine. Recurrent topics in Saurabh Nagar's work include Lymphoma Diagnosis and Treatment (7 papers), Chronic Obstructive Pulmonary Disease (COPD) Research (6 papers) and Lung Cancer Treatments and Mutations (6 papers). Saurabh Nagar is often cited by papers focused on Lymphoma Diagnosis and Treatment (7 papers), Chronic Obstructive Pulmonary Disease (COPD) Research (6 papers) and Lung Cancer Treatments and Mutations (6 papers). Saurabh Nagar collaborates with scholars based in United States, United Kingdom and Germany. Saurabh Nagar's co-authors include Anand A. Dalal, Jeetvan Patel, Keith L. Davis, James A. Kaye, Smego Ra, RK Goyal, Michelle D. Hackshaw, Mark Forshag, Anna O. D’Souza and Shaum Kabadi and has published in prestigious journals such as Journal of Clinical Oncology, SHILAP Revista de lepidopterología and Blood.

In The Last Decade

Saurabh Nagar

59 papers receiving 763 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Saurabh Nagar United States	16	376	165	133	113	97	62	775
Ancilla W. Fernandes United States	21	408 1.1×	225 1.4×	439 3.3×	193 1.7×	50 0.5×	66	1.2k
Tanya Pankhurst United Kingdom	14	200 0.5×	70 0.4×	96 0.7×	58 0.5×	39 0.4×	33	697
Sylvain Clauser France	12	170 0.5×	102 0.6×	108 0.8×	474 4.2×	162 1.7×	22	1.0k
Pamela Mancuso Italy	16	262 0.7×	55 0.3×	83 0.6×	217 1.9×	31 0.3×	63	748
Rebecca L. Olin United States	16	112 0.3×	139 0.8×	109 0.8×	454 4.0×	68 0.7×	61	1.1k
Leah J. Witt United States	15	788 2.1×	288 1.7×	342 2.6×	104 0.9×	20 0.2×	26	1.5k
Richard E. Rieselbach United States	19	290 0.8×	74 0.4×	130 1.0×	79 0.7×	97 1.0×	52	1.3k
Daniel C. Gibbons United Kingdom	12	108 0.3×	121 0.7×	101 0.8×	141 1.2×	91 0.9×	34	800
Clark DuMontier United States	16	134 0.4×	258 1.6×	60 0.5×	241 2.1×	156 1.6×	62	890
Melisa L. Wong United States	20	599 1.6×	146 0.9×	136 1.0×	728 6.4×	97 1.0×	68	1.4k

Countries citing papers authored by Saurabh Nagar

Since Specialization

Citations

This map shows the geographic impact of Saurabh Nagar's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Saurabh Nagar with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Saurabh Nagar more than expected).

Fields of papers citing papers by Saurabh Nagar

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Saurabh Nagar. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Saurabh Nagar. The network helps show where Saurabh Nagar may publish in the future.

Co-authorship network of co-authors of Saurabh Nagar

This figure shows the co-authorship network connecting the top 25 collaborators of Saurabh Nagar. A scholar is included among the top collaborators of Saurabh Nagar based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Saurabh Nagar. Saurabh Nagar is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Nagar, Saurabh, et al.. (2024). Efficacy and Efficiency of Cyanoacrylate Glue in Fistula-in-Ano. Cureus. 16(10). e72701–e72701. 1 indexed citations

Blank, Stephanie V., Saurabh Nagar, Gráinne H. Long, et al.. (2023). Real-world evaluation of PARP inhibitor tolerability in advanced ovarian cancer: Retrospective US cohort study (2209). Gynecologic Oncology. 176. S262–S263. 1 indexed citations

Esterberg, Elizabeth, Shrividya Iyer, Saurabh Nagar, Keith L. Davis, & Nizar M. Tannir. (2023). Real-World Treatment Patterns and Clinical Outcomes Among Patients With Advanced Renal Cell Carcinoma. Clinical Genitourinary Cancer. 22(2). 115–125.e3. 3 indexed citations

Nagar, Saurabh, Gaurav Chaudhary, Akhil Sharma, et al.. (2022). Correlation of lipoprotein (a) levels and plaque morphology in very young acute coronary syndrome patients using optical coherence tomography. Indian Heart Journal. 74(5). 357–362. 6 indexed citations

Goyal, RK, et al.. (2021). Overall survival, adverse events, and economic burden in patients with chronic lymphocytic leukemia receiving systemic therapy: Real‐world evidence from the medicare population. Cancer Medicine. 10(8). 2690–2702. 18 indexed citations

Shah, Riyaz, Nicolas Girard, Saurabh Nagar, et al.. (2021). European and US Real-World Treatment Patterns in Patients with Epidermal Growth Factor Receptor Mutation-Positive Non-Small Cell Lung Cancer: A Retrospective Medical Record Review. Drugs - Real World Outcomes. 8(4). 537–545. 9 indexed citations

Goyal, RK, Preetesh Jain, Saurabh Nagar, et al.. (2021). Real-world evidence on survival, adverse events, and health care burden in Medicare patients with mantle cell lymphoma. Leukemia & lymphoma. 62(6). 1325–1334. 5 indexed citations

Ueda, Kaname, et al.. (2020). <p>Longitudinal Assessment of Pain Management Among the Employed Japanese Population with Knee Osteoarthritis</p>. Clinical Interventions in Aging. Volume 15. 1003–1012. 2 indexed citations

Kabadi, Shaum, RK Goyal, Saurabh Nagar, James A. Kaye, & Keith L. Davis. (2019). Treatment patterns, adverse events, and economic burden in a privately insured population of patients with chronic lymphocytic leukemia in the United States. Cancer Medicine. 8(8). 3803–3810. 31 indexed citations

10.

Goyal, RK, Gebra Cuyún Carter, Saurabh Nagar, et al.. (2019). Treatment patterns, survival and economic outcomes in Medicare-enrolled, older patients with HR+/HER2− metastatic breast cancer. Current Medical Research and Opinion. 35(10). 1699–1710. 10 indexed citations

11.

Nagar, Saurabh, Jeetvan Patel, & Richard H. Stanford. (2018). Characteristics and health care resource use of subjects with COPD in the year before initiating LAMA monotherapy or LAMA+LABA combination therapy: A U.S. database study.. PubMed. 27(5). 40–47. 2 indexed citations

12.

Mytelka, Daniel S., María Gabriela Lorenzo, Dana Stafkey-Mailey, et al.. (2016). Advanced Soft Tissue Sarcoma: Systemic Treatment Patterns and Survival in Germany. Value in Health. 19(7). A760–A760. 2 indexed citations

13.

Mytelka, Daniel S., María Gabriela Lorenzo, Dana Stafkey-Mailey, et al.. (2016). Real-World Treatment Patterns and Outcomes for Patients with Advanced Soft Tissue Sarcoma Receiving Systemic Therapy in The United Kingdom. Value in Health. 19(7). A751–A751. 3 indexed citations

14.

Stanford, Richard H., Saurabh Nagar, Xiwu Lin, & Richard D. O’Connor. (2015). Use of ICS/LABA on Asthma Exacerbation Risk in Patients Within a Medical Group. Journal of Managed Care & Specialty Pharmacy. 21(11). 1014–1019. 2 indexed citations

15.

Patel, Jeetvan, Anand A. Dalal, & Saurabh Nagar. (2014). Indirect costs in chronic obstructive pulmonary disease: A review of the economic burden on employers and individuals in the United States. International Journal of COPD. 9. 289–289. 83 indexed citations

16.

Hackshaw, Michelle D., Ryan N. Hansen, Saurabh Nagar, et al.. (2014). Costs Associated with Health Care Resource Use in Patients with Advanced Renal Cell Carcinoma Receiving First-Line Treatment with Pazopanib Versus Sunitinib. Value in Health. 17(3). A77–A78. 1 indexed citations

17.

Hackshaw, Michelle D., et al.. (2014). Persistence and Compliance with Pazopanib in Patients with Advanced Renal Cell Carcinoma Within a U.S. Administrative Claims Database. Journal of Managed Care Pharmacy. 20(6). 603–610. 24 indexed citations

18.

Jain, Mahendra Kumar, et al.. (2013). Facial Hemiatrophy (Parry Romberg Syndrome). Research Journal of Pharmacology and Pharmacodynamics. 5(1). 83–83.

19.

Dalal, Anand A., et al.. (2012). Observational study of the outcomes and costs of initiating maintenance therapies in patients with moderate exacerbations of COPD. Respiratory Research. 13(1). 41–41. 14 indexed citations

20.

Ra, Smego, et al.. (2001). A Meta-analysis of Salvage Therapy for Pneumocystis carinii Pneumonia. Archives of Internal Medicine. 161(12). 1529–1529. 65 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact